Skip to content

Addiction: all studies

Page 668 of 857: studies 6,671 to 6,680 of 8,563, newest first. Back to the addiction overview

Research

MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner.

Archives of Toxicology August 2014 Daniel José Barbosa, Roman Serrat, Serena Mirra et al.

Identification of the mechanisms by which drugs of abuse cause neuronal dysfunction is essential for understanding the biological bases of their acute and long-lasting effects in the brain. Here, we performed real-time functional experiments of axonal transport of mitochondria to explore the role of in situ mitochondrial dysfunction in 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy")-related...

Dispositional Mindfulness Co-varies with Self-Reported Positive Reappraisal.

Personality and Individual Differences August 1, 2014 Adam W. Hanley, Eric L Garland

Emerging research suggests that mindfulness is associated with positive reappraisal and that mindfulness practice may be a means of encouraging positive reappraisal capacities. These findings, linking mindfulness with the promotion of cognitive coping strategies, challenge traditional Western conceptualizations of mindfulness as non-discursive. This study explored the relationship between...

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.

Therapeutic Advances in Psychopharmacology August 1, 2014 David Baumeister, Georgina Barnes, Giovanni Giaroli et al.

Hallucinogens have been part of spiritual practice for millennia, but controversy surrounding their mind-manifesting effects led to their proscription by the mid-20th century, largely without evidence of harm or toxicity and despite nascent data suggesting therapeutic utility in treating depressive illnesses. This review explores their pharmacodynamic actions and the current limited data on...

The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.

The International Journal of Neuropsychopharmacology August 1, 2014 Maurizio S Riga, Guadalupe Soria, Raúl Tudela et al. 75 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a natural hallucinogen component of Ayahuasca, an Amazonian beverage traditionally used for ritual, religious and healing purposes that is being increasingly used for recreational purposes in US and Europe. 5MeO-DMT is of potential interest for schizophrenia research owing to its hallucinogenic properties. Two other psychotomimetic agents,...

DOI: 10.1017/s1461145714000261 (opens in new tab) Full text (opens in new tab) Ayahuasca Hallucinogens psychedelics Natural hallucinogens Mind-altering substances +16

Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study

Drug Testing and Analysis July 28, 2014 Jordi Riba, Ethan H. Mcilhenny, José Carlos Bouso et al. 96 citations

N , N ‐dimethyltryptamine (DMT) is a widely distributed plant alkaloid that displays partial agonist activity at the 5‐HT 2A receptor and induces intense psychedelic effects in humans when administered parenterally. However, self‐administration studies have reported a total lack of activity following oral intake. This is thought to be due to extensive degradation by monoamine oxidase (MAO)....

DOI: 10.1002/dta.1685 (opens in new tab) Oral administration Urine Ingestion Pharmacology +5

Mindfulness, Free Will and Buddhist Practice: Can Meditation Enhance Human Agency?

Buddhist Studies Review July 24, 2014 Terry Hyland 7 citations

Recent philosophical and neuroscientific writings on the problem of free will have tended to consolidate the deterministic accounts with the upshot that free will is deemed to be illusory and contrary to the scientific facts (Blackmore 2011; Harris 2012). Buddhist commentaries on these issues have been concerned in the main with whether karma and dependent origination implies a causal...

Enhanced repertoire of brain dynamical states during the psychedelic experience

Human Brain Mapping July 3, 2014 Enzo Tagliazucchi, Robin Carhart-Harris, Robert Leech et al. 423 citations

Abstract The study of rapid changes in brain dynamics and functional connectivity (FC) is of increasing interest in neuroimaging. Brain states departing from normal waking consciousness are expected to be accompanied by alterations in the aforementioned dynamics. In particular, the psychedelic experience produced by psilocybin (a substance found in “magic mushrooms”) is characterized by...

DOI: 10.1002/hbm.22562 (opens in new tab) Full text (opens in new tab) Cognitive science Repertoire Communication Cognitive psychology

Psychedelic Experiential Pharmacology: Pioneering Clinical Explorations with Salvador Roquet (How I Came to All of This: Ketamine, Admixtures and Adjuvants, Don Juan and Carlos Castaneda Too): An Interview with Richard Yensen

International Journal of Transpersonal Studies July 1, 2014 Philip E. Wolfson 20 citations

Richard Yensen was a research fellow at the Maryland Psychiatric Research Center from 1972 to 1976. He studied psychedelic psychotherapy with Stanislav Grof, M.D. and other senior staff. During this time he treated patients with substance abuse disorders, cancer, neurosis, and other health professionals seeking a training experience. Dr. Yensen did his Ph.D. dissertation on the use of MDA in...

DOI: 10.24972/ijts.2014.33.2.160 (opens in new tab) Ketamine Experiential learning Psychoanalysis Psychotherapist

Posterior Cingulate Cortex-Related Co-Activation Patterns: A Resting State fMRI Study in Propofol-Induced Loss of Consciousness

PLoS One June 30, 2014 Enrico Amico, Francisco Gómez, Carol di Perri et al. 115 citations

BACKGROUND: Recent studies have been shown that functional connectivity of cerebral areas is not a static phenomenon, but exhibits spontaneous fluctuations over time. There is evidence that fluctuating connectivity is an intrinsic phenomenon of brain dynamics that persists during anesthesia. Lately, point process analysis applied on functional data has revealed that much of the information...

DOI: 10.1371/journal.pone.0100012 (opens in new tab) Default mode network Posterior cingulate Unconsciousness Resting State FMRI +10

No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation

PLoS One June 27, 2014 Kim P. C. Kuypers, Rafael de la Torre, Magı́ Farré et al. 88 citations

The present study aimed at investigating the effect of MDMA on measures of empathy and social interaction, and the roles of oxytocin and the 5-HT1A receptor in these effects. The design was placebo-controlled within-subject with 4 treatment conditions: MDMA (75 mg), with or without pindolol (20 mg), oxytocin nasal spray (40 IU+16 IU) or placebo. Participants were 20 healthy poly-drug MDMA...

DOI: 10.1371/journal.pone.0100719 (opens in new tab) MDMA Empathy Pindolol Oxytocin receptor +3